- RecruitingPHASE2
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
This study is testing a new inhaled medicine (AP01) for people with progressive pulmonary fibrosis. It aims to see if it's safe and effective, compared to a dummy medicine, over one year, alongside usual care.
For: Pulmonary Fibrosis · Progressive Pulmonary Fibrosis · Pulmonary Fibrosis Secondary to Systemic SclerosisUnited States · Argentina · Australia - RecruitingPHASE2
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
This study is for people who were in a previous study with an inhaled medicine called AP01 for lung scarring (pulmonary fibrosis). It’s an extension to see how the medicine works over a longer time, using an inhaler twice a day.
For: Progressive Pulmonary Fibrosis · Idiopathic Pulmonary Fibrosis (IPF)United States · Australia · Canada